Search

everythinglearnresearchcommunity

for

Search:↓

The treatment is safe and shows promise for metastatic breast cancer.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

Nab-paclitaxel is as effective as cisplatin but safer for early-stage cervical cancer treatment.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Doxil's toxicity varies with dose and schedule, and pharmacokinetic guidance can optimize dosing.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

The committee decided not to approve the drug due to low effectiveness and high risks.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

The treatment was effective and tolerable for advanced gastric cancer.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Promising cancer treatments were found, but the manufacturer closed.

Etoposide makes radiation therapy more effective against tumors without major side effects.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.